標(biāo)題: Titlebook: Clinical Trials in Latin America: Where Ethics and Business Clash; Nuria Homedes,Antonio Ugalde Book 2014 Springer International Publishin [打印本頁(yè)] 作者: 積聚 時(shí)間: 2025-3-21 16:16
書(shū)目名稱(chēng)Clinical Trials in Latin America: Where Ethics and Business Clash影響因子(影響力)
書(shū)目名稱(chēng)Clinical Trials in Latin America: Where Ethics and Business Clash影響因子(影響力)學(xué)科排名
書(shū)目名稱(chēng)Clinical Trials in Latin America: Where Ethics and Business Clash網(wǎng)絡(luò)公開(kāi)度
書(shū)目名稱(chēng)Clinical Trials in Latin America: Where Ethics and Business Clash網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書(shū)目名稱(chēng)Clinical Trials in Latin America: Where Ethics and Business Clash被引頻次
書(shū)目名稱(chēng)Clinical Trials in Latin America: Where Ethics and Business Clash被引頻次學(xué)科排名
書(shū)目名稱(chēng)Clinical Trials in Latin America: Where Ethics and Business Clash年度引用
書(shū)目名稱(chēng)Clinical Trials in Latin America: Where Ethics and Business Clash年度引用學(xué)科排名
書(shū)目名稱(chēng)Clinical Trials in Latin America: Where Ethics and Business Clash讀者反饋
書(shū)目名稱(chēng)Clinical Trials in Latin America: Where Ethics and Business Clash讀者反饋學(xué)科排名
作者: 無(wú)目標(biāo) 時(shí)間: 2025-3-21 23:19
Book 2014 Agency has defined them as priority countries in Latin America. The authors raise questions about the quality of data obtained from the trials and the violation of human rights during their implementation. Their findings are presented in this volume, the first in-depth analysis of clinical trials in the region. ? ? ? ? ?作者: 否認(rèn) 時(shí)間: 2025-3-22 01:04
Nigel Hoschke,Don C. Price,D. Andrew Scott, Brazil, Costa Rica, Mexico and Peru) where about 80 % of all clinical trials in the region take place and the circumstances that have left some clinical research participants insufficiently protected. A very brief summary of the highlights of each chapter is included.作者: 辯論 時(shí)間: 2025-3-22 05:03 作者: crease 時(shí)間: 2025-3-22 11:06
Book 2014al information and field work in Argentina, Brazil, Costa Rica, Mexico and Peru, the authors discuss the regulatory contexts and the ethical dimensions of human experimentation in the region. More than 80% of all clinical trials in the region take place in these countries, and the European Medicines作者: tendinitis 時(shí)間: 2025-3-22 15:40 作者: tendinitis 時(shí)間: 2025-3-22 17:48
Globalization and Clinical Research in Latin America,of the industry while protecting the rights of clinical trial participants. Using regional information, the authors question if the Latin American context guarantees the protection of the human rights of the participants and their communities, and the integrity of scientific inquiry. The consequence作者: 卷發(fā) 時(shí)間: 2025-3-22 22:37
The Regulatory Framework and Case Studies from Argentina,ties and informed journalists, this chapter describes cases where researchers failed to obtain informed consent, duplicated patient records, and violated inclusion and exclusion criteria. The studies that have generated controversy were financed by multinational companies and involved treatments for作者: Hyperlipidemia 時(shí)間: 2025-3-23 01:30 作者: 粉筆 時(shí)間: 2025-3-23 07:26 作者: ELUDE 時(shí)間: 2025-3-23 10:42
Progress and Challenges of Clinical Research with New Medications in Brazil,orted here..The chapter ends with an analysis of the remaining challenges to ensure that clinical research responds to the needs of the Brazilian population and is conducted in a manner that respects the rights of the participants and the integrity of the scientific process.作者: MULTI 時(shí)間: 2025-3-23 16:54 作者: 退潮 時(shí)間: 2025-3-23 18:21 作者: evasive 時(shí)間: 2025-3-23 23:15 作者: insincerity 時(shí)間: 2025-3-24 06:09 作者: Altitude 時(shí)間: 2025-3-24 09:40 作者: 珊瑚 時(shí)間: 2025-3-24 13:41
Conclusion,ome countries will have to fight for a more ethical way of conducting clinical trials. In our opinion, the trials will need to be implemented by institutions that do not have monetary incentives. It may take some time before the change occurs, but it will happen.作者: glucagon 時(shí)間: 2025-3-24 15:07
Clinical Trials in Latin America: Where Ethics and Business Clash作者: visual-cortex 時(shí)間: 2025-3-24 20:36
2212-9529 ns about the quality of data obtained from the trials and the violation of human rights during their implementation. Their findings are presented in this volume, the first in-depth analysis of clinical trials in the region. ? ? ? ? ?978-3-319-34700-4978-3-319-01363-3Series ISSN 2212-9529 Series E-ISSN 2212-9537 作者: 鳥(niǎo)籠 時(shí)間: 2025-3-25 01:43 作者: 斜 時(shí)間: 2025-3-25 03:29
Tino Schlegel,Ryszard Kowalczykof the industry while protecting the rights of clinical trial participants. Using regional information, the authors question if the Latin American context guarantees the protection of the human rights of the participants and their communities, and the integrity of scientific inquiry. The consequence作者: BOON 時(shí)間: 2025-3-25 08:02
Nicholas J. Macias,Lisa J. K. Durbeckties and informed journalists, this chapter describes cases where researchers failed to obtain informed consent, duplicated patient records, and violated inclusion and exclusion criteria. The studies that have generated controversy were financed by multinational companies and involved treatments for作者: 邊緣帶來(lái)墨水 時(shí)間: 2025-3-25 14:45
Nicholas J. Macias,Lisa J. K. Durbeckpal hospital and health centers the provincial political leaders opened the doors of provincial health facilities, where they continued the implementation of clinical trials. In one instance, they conducted a trial despite the objection of the National Ministry of Justice. Eventually, one principal 作者: 漂亮 時(shí)間: 2025-3-25 18:21 作者: Intractable 時(shí)間: 2025-3-25 22:29
Nicholas J. Macias,Lisa J. K. Durbeckorted here..The chapter ends with an analysis of the remaining challenges to ensure that clinical research responds to the needs of the Brazilian population and is conducted in a manner that respects the rights of the participants and the integrity of the scientific process.作者: palette 時(shí)間: 2025-3-26 03:02 作者: gene-therapy 時(shí)間: 2025-3-26 06:59 作者: 夾死提手勢(shì) 時(shí)間: 2025-3-26 08:51 作者: Hypomania 時(shí)間: 2025-3-26 13:03
Advances in Applied Strategic Mine Plannings forces a high number of the patients to participate in clinical trials as their only means to obtain treatment. These results could be used to revise institutional policy and design programs to improve the relationship between physicians, patients and their families; to increase patient/family und作者: 變形 時(shí)間: 2025-3-26 20:17 作者: 鈍劍 時(shí)間: 2025-3-26 22:54
Conference proceedings 2022Latest editionome countries will have to fight for a more ethical way of conducting clinical trials. In our opinion, the trials will need to be implemented by institutions that do not have monetary incentives. It may take some time before the change occurs, but it will happen.作者: 圓柱 時(shí)間: 2025-3-27 04:38
Clinical Trials in Latin America: Where Ethics and Business Clash978-3-319-01363-3Series ISSN 2212-9529 Series E-ISSN 2212-9537 作者: 配置 時(shí)間: 2025-3-27 09:01
Nigel Hoschke,Don C. Price,D. Andrew Scotthics (Red Latino Americana de ética y Medicamentos –RELEM) and to the preparation of this manuscript. As the pharmaceutical markets and pharmaceutical research is increasingly globalized, the need to create global networks to promote access and the appropriate use of pharmaceuticals and the rights o作者: 比目魚(yú) 時(shí)間: 2025-3-27 10:16
Nigel Hoschke,Don C. Price,D. Andrew Scottnalyzes the different ethical codes that have been accepted by governments and professional associations in Latin American countries. After describing how the different international ethical research codes were drafted, have been changed and are being applied, the authors characterize the reasons wh作者: exhibit 時(shí)間: 2025-3-27 14:48 作者: organism 時(shí)間: 2025-3-27 21:00 作者: Cupidity 時(shí)間: 2025-3-28 01:24
Nicholas J. Macias,Lisa J. K. Durbecks total population. This chapter describes the evolution of the provincial regulatory framework, the organizational environment that allowed the development of a private research center within the premises of a public hospital, and the ensuing collusion between researchers and clinicians..Changes of作者: 過(guò)于平凡 時(shí)間: 2025-3-28 03:06
Self-Organizing Digital Systemsmerican investigators. The country’s return to democracy and the documentation of ethical abuses while conducting clinical trials triggered the need to develop norms and regulations..The chapter describes the process followed by the National Health Council, an entity created to increase social contr作者: 馬具 時(shí)間: 2025-3-28 06:21 作者: 高談闊論 時(shí)間: 2025-3-28 13:43
Tino Schlegel,Ryszard Kowalczykll country concentrates a disproportionate number of clinical trials, especially with pediatric populations, which are conducted by a handful of physicians. The regulation of clinical trials is incomplete and its analysis reflects the tensions among four different interest groups: (1) The Ministry o作者: Modify 時(shí)間: 2025-3-28 17:15
S. Khosrowshahi,W. J. Shaw,G. A. Yeateses to determine the causes of cervical cancer. Most of those studies were conducted in one of Costa Rica’s poorest rural regions with a high incidence of HPV infection, and involved thousands of healthy young women. Undoubtedly the results of these studies are of high scientific and economic value, 作者: xanthelasma 時(shí)間: 2025-3-28 21:39 作者: Abominate 時(shí)間: 2025-3-28 23:19 作者: 同時(shí)發(fā)生 時(shí)間: 2025-3-29 03:21 作者: flutter 時(shí)間: 2025-3-29 07:40 作者: SMART 時(shí)間: 2025-3-29 14:34
https://doi.org/10.1007/978-3-319-01363-3Argentina bioethics; Clinical Trials; Ethics and business; Latin America; Outsourcing clinical trials; cl作者: Cupidity 時(shí)間: 2025-3-29 16:55 作者: 語(yǔ)言學(xué) 時(shí)間: 2025-3-29 19:44
Nuria Homedes,Antonio UgaldeFirst book to give an overview of the outsourcing of clinical trials in Latin America.Raises questions about the quality of data obtained from the trials and the violation of human rights during their作者: Irascible 時(shí)間: 2025-3-30 02:47 作者: Latency 時(shí)間: 2025-3-30 06:29
Introduction,hics (Red Latino Americana de ética y Medicamentos –RELEM) and to the preparation of this manuscript. As the pharmaceutical markets and pharmaceutical research is increasingly globalized, the need to create global networks to promote access and the appropriate use of pharmaceuticals and the rights o作者: 無(wú)畏 時(shí)間: 2025-3-30 09:02
A Review and Critique of International Ethical Principles,nalyzes the different ethical codes that have been accepted by governments and professional associations in Latin American countries. After describing how the different international ethical research codes were drafted, have been changed and are being applied, the authors characterize the reasons wh作者: 不合 時(shí)間: 2025-3-30 13:58
Globalization and Clinical Research in Latin America,option of the Agreement on Trade Related Aspects of Intellectual Property Rights (TRIPS) and the approval of the Good Clinical Practice Guidelines from the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH GCP)..This chapter de作者: OFF 時(shí)間: 2025-3-30 16:59
The Regulatory Framework and Case Studies from Argentina,s and the responsibility for clinical trials rests in the provinces. Nevertheless the federal Ministry of Health and the regulatory agency (ANMAT) have a number of regulations and the country can be characterized as having an uneven but evolving legal infrastructure. This chapter describes the regul作者: Hay-Fever 時(shí)間: 2025-3-30 23:03 作者: 預(yù)測(cè) 時(shí)間: 2025-3-31 01:01
